Skip to main content
From Bio Co., Ltd. logo

From Bio Co., Ltd. — Investor Relations & Filings

Ticker · 377220 ISIN · KR7377220009 KO Manufacturing
Open in API
Filings indexed 112 across all filing types
Latest filing 2024-04-03 Director's Dealing
Country KR South Korea
Listing KO 377220

About From Bio Co., Ltd.

https://frombio-company.co.kr/default/e…

From Bio Co., Ltd. is a healthcare company specializing in the research, development, manufacturing, and sale of health functional foods and dietary supplements. The company operates across the entire value chain, from sourcing new raw materials to production in its GMP-certified facility. A significant focus is placed on research and development through its specialized Food, Bio, and New Drug laboratories. These divisions work on discovering and verifying novel functional ingredients for health foods while also developing new pharmaceuticals, including treatments for alopecia and first-in-class drugs. The product portfolio addresses specific health needs such as joint health (Boswellia), stomach comfort (Mastic Gum), eye health (Bilberry), and body fat reduction (Wild Mango), emphasizing the use of natural, plant-based ingredients.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the change in share ownership by an executive (Kim Ji-hoon) of FromBio due to resignation. This type of filing is a standard regulatory disclosure for insider share transactions or changes in ownership status, which falls under the 'Director's Dealing' category.
2024-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (AGM). It details the voting outcomes for various agenda items, including financial statement approval, director appointments, and remuneration limits. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2024-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically the appointment and reappointment of outside directors for the company 'Frombio'. This falls under the category of Board/Management Information (MANG), which covers announcements of changes in the board of directors or senior management.
2024-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company PromBio. It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a regulatory filing specifically announcing the submission of the audit report to the exchange, which is a standard requirement for public companies. Given the structure and content, it falls under the category of Audit Report / Information. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'FromBio' (주식회사 프롬바이오) for the fiscal year ending December 31, 2023. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an earnings release or a summary, and it is not an annual report (10-K) in the sense of a full regulatory filing containing business descriptions and management discussion, but rather the standalone audit report and financial statements. Therefore, it is classified as an Audit Report (AR). FY 2023
2024-03-20 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for FromBio Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as board activities and financial summaries for the upcoming meeting. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on company matters.
2024-03-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.